Results of the Russian Society of Cardiology survey "Chronic heart failure. Unsolved issues"

QR Code

Results of the Russian Society of Cardiology survey "Chronic heart failure. Unsolved issues"

Aim. To analyze the readiness of the professional medical community for changes in the classification and implementation of novel approaches to heart failure (HF) treatment based on an online survey.Material and methods. Anonymous online survey of physicians on the official website of the Russian So...

Full description

Saved in:

Bibliographic Details
Main Authors:	O. B. Irtyuga, S. V. Nedogoda, М. Yu. Sitnikova M.Yu., А. S. Galyavich, S. V. Villevalde, A. O. Nedoshivin, A. O. Konradi, E. V. Shlyakhto
Format:	Article
Language:	Russian
Published:	«FIRMA «SILICEA» LLC 2024-06-01
Series:	Российский кардиологический журнал
Subjects:	heart failure classification ejection fraction
Online Access:	https://russjcardiol.elpub.ru/jour/article/view/5944
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

About the classification of heart failure
by: A. S. Galyavich, et al.
Published: (2023-09-01)

New draft classification of chronic heart failure of the Russian Society of Cardiology: are there any obvious advantages over the current ones?
by: V. V. Kalyuzhin, et al.
Published: (2024-04-01)

Molecular biomarker profile of heart failure with mid-range and preserved ejection fraction in patients with type 2 diabetes
by: D. A. Lebedev, et al.
Published: (2020-11-01)

Role of ratio-based metrics in cardiology
by: A. O. Konradi, et al.
Published: (2020-11-01)

Microcirculation in heart failure: state of the art (literature review)
by: I. M. Davidovich, et al.
Published: (2025-02-01)

Biomarkers in the Pathogenesis of Heart Failure with Preserved as Well as Reduced Ejection Fraction: A Cross-sectional Study
by: Sowmiya Thiyagarajan, et al.
Published: (2025-06-01)

Interim analysis of a prospective observational multicenter registry study of patients with chronic heart failure in the Russian Federation "PRIORITET-CHF": initial characteristics and treatment of the first included patients
by: E. V. Shlyakhto, et al.
Published: (2023-11-01)

Lipoprotein(a) and Heart Failure Among Black and White Participants in Atherosclerosis Risk in Communities Study, Framingham Offspring Study, and Multi‐Ethnic Study of Atherosclerosis: The Pooling Project
by: Sarah Nomura, et al.
Published: (2025-06-01)

Phenotypic clusters in heart failure with preserved and mid-range ejection fraction: new data and perspectives
by: O. V. Tsygankova, et al.
Published: (2021-05-01)

Effect of therapy on the dynamics of collagen metabolism markers in older patients with heart failure with mid-range ejection fraction and coronary artery disease
by: O. A. Osipova, et al.
Published: (2020-11-01)

Pharmacoepidemiological analysis of routine management of heart failure patients in the Russian Federation. Part I
by: Yu. M. Lopatin, et al.
Published: (2021-05-01)

EURASIAN ASSOCIATION OF CARDIOLOGY (EAC)/ NATIONAL SOCIETY OF HEART FAILURE AND MYOCARDIAL DISEASE (NSHFMD) GUIDELINES FOR THE DIAGNOSIS AND TREATMENT OF CHRONIC HEART FAILURE (2020)
by: S. N. Tereshchenko, et al.
Published: (2020-09-01)

Features of chronic heart failure depending on the left ventricular ejection fraction
by: A. G. Dushina, et al.
Published: (2019-03-01)

Correlation of β-adrenergic reactivity of erythrocyte membranes with clinical characteristics of patients with coronary artery disease and HF with preserved and reduced ejection fraction
by: E. F. Muslimova, et al.
Published: (2025-01-01)

Assessment of prevalence and monitoring of outcomes in patients with heart failure in Russia
by: E. V. Shlyakhto, et al.
Published: (2020-12-01)

Markers of heart failure with preserved ejection fraction in patients with unexplained dyspnea
by: A. A. Ivanova, et al.
Published: (2023-11-01)

Clinical and prognostic value of determining the level of neopterin in patients with chronic heart failure with preserved ejection fraction
by: O. S. Polunina, et al.
Published: (2018-10-01)

Chronic Heart Failure with Preserved Ejection Fraction in A Comorbid Patient: Issues in Verification of A «Difficult» Diagnosis
by: O. V. Ponomareva, et al.
Published: (2025-05-01)

Eurasian Association of Cardiology (EAC)/ National Society of Heart Failure And Myocardial Disease (NSHFMD) guidelines for the diagnosis and treatment of chronic heart failure (2024)
by: S. N. Tereshchenko, et al.
Published: (2024-05-01)

The role of free nucleotides in heart failure
by: E. V. Kolesnikova, et al.
Published: (2025-03-01)

Features of structural and geometric remodeling of the heart and changes in the diastolic filling of the heart in patients with chronic heart failure of ischemic genesis with preserved left ventricular ejection fraction
by: V. A. Lysenko, et al.
Published: (2021-03-01)

Dynamics of heart failure markers and cardiac reverse remodeling in patients receiving cardiac contractility modulation therapy
by: M. A. Vander, et al.
Published: (2021-02-01)

Low-intensity inflammation as a manifestation of comorbidity and a factor in the unfavorable clinical course of heart failure with preserved ejection fraction
by: K. N. Vitt, et al.
Published: (2024-03-01)

Effect of Noncardiac Comorbidities on Quality of Life among Patients with Heart Failure - An Observational Study
by: J. Anusha, et al.
Published: (2025-07-01)

Rationale for dapagliflozin administration for the prevention of adverse outcomes in patients with heart failure with reduced ejection fraction. Expert consensus statement
by: S. N. Tereshchenko, et al.
Published: (2020-06-01)

Prognostic significance of NT-proBNP and sST2 in patients with heart failure with preserved and mildly reduced ejection fraction
by: V. I. Podzolkov, et al.
Published: (2023-10-01)

PATIENT WITH CHRONIC HEART FAILURE. RATIONAL CHOICE OF THERAPY
by: O. M. Drapkina, et al.
Published: (2017-09-01)

Features of phenotyping patients with heart failure with preserved ejection fraction
by: E. K. Serezhina, et al.
Published: (2023-09-01)

Cardiorenal relationships in patients with chronic heart failure with preserved ejection fraction
by: Yu. N. Panina, et al.
Published: (2023-11-01)

Pharmacoepidemiological analysis of routine management of heart failure patients in the Russian Federation. Part II
by: S. V. Nedogoda, et al.
Published: (2022-03-01)

Adherence to treatment as an integral component of the management of patients with heart failure
by: V. N. Larina, et al.
Published: (2024-02-01)

GALECTIN-3 AND NT-proBNP AS BIOMARKERS OF HEART FAILURE DECOMPENSATION
by: Yu. V. Dubolazova, et al.
Published: (2017-02-01)

Characteristics of patients with chronic heart failure with mildly reduced ejection fraction: clinical and demographic aspect
by: M. T. Duishenalieva, et al.
Published: (2025-05-01)

Heart Failure with Perserved Ejection Fraction Current Diagnostic and Therapeutic Approaches
by: A. A. Shchendrygina, et al.
Published: (2021-07-01)

EFFECTS OF SACUBITRIL/VALSARTAN ON THE ARTERIAL STIFFNESS AND LEFT VENTRICULAR-ARTERIAL COUPLING IN PATIENTS WITH HEART FAILURE WITH REDUCED EJECTION FRACTION
by: Zh. D. Kobalava, et al.
Published: (2018-05-01)

Beta-blockers in chronic heart failure with preserved left ventricular ejection fraction: is deprescribing possible?
by: V. D. Zakiev, et al.
Published: (2023-12-01)

Advanced glycation end products, galectin-3, matrix metalloproteinase-9 activity in men with heart failure and concomitant benign prostatic hyperplasia with androgen deficiency
by: V.S. Nedzvetsky, et al.
Published: (2021-12-01)

<i>RBM20</i> gene variants associated with left atrial dilatation in patients with old myocardial infarction and heart failure with reduced ejection fraction
by: Yu. A. Vakhrushev, et al.
Published: (2021-11-01)

First-phase ejection fraction is associated with myocardial fibrosis in the pressure overloaded heart
by: Shukun He, et al.
Published: (2025-07-01)

Prediction model of rehospitalization and mortality in heart failure patients with preserved and mildly reduced ejection fraction: the AD2NNER risk score
by: Flavia-Mihaela Stoiculescu, et al.
Published: (2025-07-01)